Overview
Marcel Meima practices in Rotterdam, Netherlands. Mr. Meima is rated as a Distinguished expert by MediFind in the treatment of Generalized Resistance to Thyroid Hormone. His top areas of expertise are Familial Hyperthyroidism due to Mutations in TSH Receptor, Generalized Resistance to Thyroid Hormone, Allan-Herndon-Dudley Syndrome, and Hypotonia.
His clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Generalized Resistance to Thyroid Hormone.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Allan-Herndon-Dudley SyndromeMr. Meima isDistinguished. Learn about Allan-Herndon-Dudley Syndrome.
- Familial Hyperthyroidism due to Mutations in TSH Receptor
- Generalized Resistance to Thyroid HormoneMr. Meima isDistinguished. Learn about Generalized Resistance to Thyroid Hormone.
- Advanced
- HypotoniaMr. Meima isAdvanced. Learn about Hypotonia.
- Experienced
- HypertensionMr. Meima isExperienced. Learn about Hypertension.
- HypothyroidismMr. Meima isExperienced. Learn about Hypothyroidism.
- Muscle AtrophyMr. Meima isExperienced. Learn about Muscle Atrophy.
- Neonatal HypothyroidismMr. Meima isExperienced. Learn about Neonatal Hypothyroidism.
- Neurotoxicity SyndromesMr. Meima isExperienced. Learn about Neurotoxicity Syndromes.